Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,400.00 at Wells Fargo & Company

Mettler-Toledo International (NYSE:MTD) had its target price upped by Wells Fargo & Company from $1,350.00 to $1,400.00 in a research report report published on Monday morning,Benzinga reports. They currently have an equal weight rating on the medical instruments supplier’s stock.

Several other equities analysts also recently weighed in on the stock. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and lifted their target price for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and lifted their price objective for the company from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. Wolfe Research initiated coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating on the stock. Stifel Nicolaus reduced their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Finally, Robert W. Baird increased their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a report on Monday. One analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Mettler-Toledo International has a consensus rating of “Hold” and a consensus price target of $1,368.00.

Mettler-Toledo International Trading Down 3.6 %

NYSE:MTD opened at $1,339.46 on Monday. Mettler-Toledo International has a 12 month low of $1,133.46 and a 12 month high of $1,546.93. The firm’s 50 day moving average is $1,278.92 and its 200 day moving average is $1,342.95. The stock has a market capitalization of $28.26 billion, a PE ratio of 33.05, a price-to-earnings-growth ratio of 4.80 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 564.51% and a net margin of 22.29%. Research analysts predict that Mettler-Toledo International will post 41.94 earnings per share for the current year.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the transaction, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. The trade was a 95.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.94% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

Large investors have recently modified their holdings of the company. Proficio Capital Partners LLC purchased a new position in shares of Mettler-Toledo International during the fourth quarter worth approximately $163,216,000. International Assets Investment Management LLC raised its position in Mettler-Toledo International by 149,870.0% in the 3rd quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock worth $134,946,000 after purchasing an additional 89,922 shares during the period. Seilern Investment Management Ltd bought a new stake in Mettler-Toledo International in the fourth quarter worth $89,221,000. AustralianSuper Pty Ltd boosted its position in Mettler-Toledo International by 3,183.2% during the fourth quarter. AustralianSuper Pty Ltd now owns 71,673 shares of the medical instruments supplier’s stock valued at $87,705,000 after buying an additional 69,490 shares during the period. Finally, Canoe Financial LP grew its stake in shares of Mettler-Toledo International by 576.5% during the fourth quarter. Canoe Financial LP now owns 55,518 shares of the medical instruments supplier’s stock valued at $67,936,000 after buying an additional 47,311 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.